CATALAYER NEWS
AstraZeneca cuts US drug pricing deal; FDA declares Novo plant out of compliance - BioPharma Dive
Source: BioPharma Dive · 2025-10-14
Full article text is available in the Catalayer news terminal.
RELATED ON CATALAYER
Mentioned Tickers
$AZN · AstraZenecaRelated Topics
Biotech & FDA NewsRELATED MARKETS
Prediction Markets